G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist
1 other identifier
interventional
58
1 country
1
Brief Summary
The purpose of this study is to compare the adenoma detection rate of G-EYE™ high definition colonoscopy with that of standard high definition colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable colorectal-cancer
Started Nov 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 10, 2014
CompletedFirst Posted
Study publicly available on registry
February 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFebruary 12, 2016
February 1, 2016
2.1 years
February 10, 2014
February 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
G-EYE™ colonoscopy detection rate of adenomas and serrated lesions compared to the standard colonoscopy detection rate of the same.
estimated 14 days (following histology results)
Secondary Outcomes (1)
polyp and adenoma detection, procedure times and safety
24-72 hours post procedure
Study Arms (2)
Group A
EXPERIMENTALSubjects will undergo complete standard colonoscopy, followed by G-EYE(TM) Colonoscopy
Group B
ACTIVE COMPARATORSubject will undergo G-EYE(TM) colonoscopy followed by standard colonoscopy
Interventions
Eligibility Criteria
You may qualify if:
- Patients over 50 years old
- Referred to colonoscopy for screening, following positive FOBT testing, change of bowel habits or for surveillance colonoscopy (history of adenoma resection).
- The patient must understand and provide written consent for the procedure.
You may not qualify if:
- Subjects with inflammatory bowel disease;
- Subjects with a personal history of polyposis syndrome;
- Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
- Subjects with diverticulitis or toxic megacolon;
- Subjects with a history of radiation therapy to abdomen or pelvis;
- Pregnant or lactating female subjects;
- Subjects who are currently enrolled in another clinical investigation.
- Subjects with current oral or parenteral use of anticoagulants
- Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Marienkrankenhaus Frankfurt
Frankfurt, 60318, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ralf Kiesslich, Prof.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2014
First Posted
February 19, 2014
Study Start
November 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
February 12, 2016
Record last verified: 2016-02